Cantor Fitzgerald Analyst Ratings & Stock Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cantor Fitzgerald. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cantor Fitzgerald.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
3/19/2019Cantor FitzgeraldReiteratesEvolus (EOLS)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2019Cantor FitzgeraldSet Price TargetPolarityte (PTE)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2019Cantor FitzgeraldReiteratesAurinia Pharmaceuticals (AUPH)Buy$18.00 -> $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2019Cantor FitzgeraldSet Price TargetNovavax (NVAX)Hold $1.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2019Cantor FitzgeraldSet Price TargetAbeona Therapeutics (ABEO)Buy $29.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/19/2019Cantor FitzgeraldReiteratesCatalyst Pharmaceuticals (CPRX)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/19/2019Cantor FitzgeraldRaises TargetHealthequity (HQY)Overweight$83.00 -> $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2019Cantor FitzgeraldReiteratesSpero Therapeutics (SPRO)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2019Cantor FitzgeraldReiteratesExela Technologies (XELA)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/18/2019Cantor FitzgeraldReiteratesAscendis Pharma A/S (ASND)Buy $185.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/18/2019Cantor FitzgeraldReiteratesTAIWAN LIPOSOME/S (TLC)Buy $11.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/18/2019Cantor FitzgeraldReiteratesGW Pharmaceuticals PLC- (GWPH)Overweight -> Overweight$193.00 -> $196.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/18/2019Cantor FitzgeraldLowers TargetRA Medical Systems (RMED)Overweight$21.00 -> $11.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2019Cantor FitzgeraldReiteratesAclaris Therapeutics (ACRS)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2019Cantor FitzgeraldRaises TargetAxsome Therapeutics (AXSM)Overweight$13.00 -> $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/14/2019Cantor FitzgeraldReiteratesBioDelivery Sciences International (BDSI)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/14/2019Cantor FitzgeraldReiteratesAMAG Pharmaceuticals (AMAG)Hold$17.00 -> $14.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/13/2019Cantor FitzgeraldReiteratesInternational Money Express (IMXI)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2019Cantor FitzgeraldReiteratesGalmed Pharmaceuticals (GLMD)Buy $59.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/12/2019Cantor FitzgeraldReiteratesCorbus Pharmaceuticals (CRBP)Buy $38.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/11/2019Cantor FitzgeraldInitiatesCrinetics Pharmaceuticals (CRNX)Overweight $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2019Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2019Cantor FitzgeraldSet Price TargetCollegium Pharmaceutical (COLL)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2019Cantor FitzgeraldReiteratesBioDelivery Sciences International (BDSI)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
3/8/2019Cantor FitzgeraldDowngradesMcEwen Mining (MUX)Overweight -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2019Cantor FitzgeraldSet Price TargetHTG Molecular Diagnostics (HTGM)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/7/2019Cantor FitzgeraldReiteratesOcular Therapeutix (OCUL)Buy $24.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/7/2019Cantor FitzgeraldReiteratesZynerba Pharmaceuticals (ZYNE)Buy $11.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/7/2019Cantor FitzgeraldReiteratesUniqure (QURE)Buy $81.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/7/2019Cantor FitzgeraldInitiatesChiasma (CHMA)Overweight $5.84MediumView Rating Details  Share on Twitter  Share on StockTwits
3/6/2019Cantor FitzgeraldInitiatesUnity Biotechnology (UBX)Overweight -> Overweight $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/6/2019Cantor FitzgeraldRaises TargetBiohaven Pharmaceutical (BHVN)Overweight $82.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/5/2019Cantor FitzgeraldSet Price TargetAerpio Pharmaceuticals (ARPO)Buy $8.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2019Cantor FitzgeraldSet Price TargetT2 Biosystems (TTOO)Buy $11.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/5/2019Cantor FitzgeraldInitiatesVoyager Therapeutics (VYGR)Overweight $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/5/2019Cantor FitzgeraldReiteratesKindred Biosciences (KIN)Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Cantor FitzgeraldDowngradesHeron Therapeutics (HRTX)Overweight -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Cantor FitzgeraldReiteratesOtonomy (OTIC)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Cantor FitzgeraldInitiatesMirati Therapeutics (MRTX)Neutral $66.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Cantor FitzgeraldReiteratesMerck & Co., Inc. (MRK)Buy $95.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Cantor FitzgeraldReiteratesMyokardia (MYOK)Buy $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Cantor FitzgeraldReiteratesAscendis Pharma A/S (ASND)Overweight$102.00 -> $185.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Cantor FitzgeraldInitiatesProthena (PRTA)Overweight $13.77HighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Cantor FitzgeraldReiteratesEvofem Biosciences (EVFM)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Cantor FitzgeraldDowngradesNightstar Therapeutics (NITE)Overweight -> Neutral$42.00 -> $25.50HighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Cantor FitzgeraldRaises TargetBioMarin Pharmaceutical (BMRN)Positive -> Overweight $131.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/3/2019Cantor FitzgeraldReiteratesGenpact (G)Buy $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/1/2019Cantor FitzgeraldReiteratesGlobus Medical (GMED)Buy $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldSet Price TargetApellis Pharmaceuticals (APLS)Buy $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldSet Price TargetHalozyme Therapeutics (HALO)Buy $24.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldReiteratesRigel Pharmaceuticals (RIGL)Overweight -> Buy$9.00 -> $7.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldSet Price TargetCymaBay Therapeutics (CBAY)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldSet Price TargetAimmune Therapeutics (AIMT)Buy $45.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldReiteratesTabula Rasa HealthCare (TRHC)Buy $99.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldReiteratesPuma Biotechnology (PBYI)Buy $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldReiteratesPTC Therapeutics (PTCT)Buy $61.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldReiteratesReata Pharmaceuticals (RETA)Buy $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldReiteratesAmneal Pharmaceuticals (AMRX)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldReiteratesIntercept Pharmaceuticals (ICPT)Overweight -> Overweight$170.00 -> $191.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldReiteratesEagle Pharmaceuticals (EGRX)Hold $58.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/28/2019Cantor FitzgeraldRaises TargetSarepta Therapeutics (SRPT)Overweight -> Overweight$217.00 -> $231.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldReiteratesMenlo Therapeutics (MNLO)Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldReiteratesSquare (SQ)Buy $91.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldReiteratesTeladoc Health (TDOC)Neutral -> Hold$83.00 -> $70.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldReiteratesAnaptysBio (ANAB)Buy $140.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldReiteratesCentene (CNC)Buy $83.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldRaises TargetWorldpay (WP)Overweight -> Overweight$105.00 -> $110.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldRaises TargetWright Medical Group (WMGI)Overweight -> Overweight$35.00 -> $39.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldReiteratesSupernus Pharmaceuticals (SUPN)Buy $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldLowers TargetEvolent Health (EVH)Overweight -> Overweight$37.00 -> $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldReiteratesGW Pharmaceuticals PLC- (GWPH)Buy $193.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Cantor FitzgeraldReiteratesACADIA Pharmaceuticals (ACAD)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldSet Price TargetAerie Pharmaceuticals (AERI)Buy $85.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldSet Price TargetEvofem Biosciences (EVFM)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldSet Price TargetCorcept Therapeutics (CORT)Hold $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldSet Price TargetStrongbridge Biopharma (SBBP)Buy $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldReiteratesArena Pharmaceuticals (ARNA)Buy $62.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldReiteratesDynavax Technologies (DVAX)Overweight -> Overweight$32.00 -> $28.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldSet Price TargetJazz Pharmaceuticals (JAZZ)Buy $185.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldReiteratesTheravance Biopharma (TBPH)Buy $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldReiteratesAlder Biopharmaceuticals (ALDR)Hold $14.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldReiteratesSpero Therapeutics (SPRO)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldReiteratesWorldpay (WP)Buy $105.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldReiteratesNightstar Therapeutics (NITE)Buy $42.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Cantor FitzgeraldReiteratesAmicus Therapeutics (FOLD)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/25/2019Cantor FitzgeraldReiteratesUniqure (QURE)Overweight -> Overweight$68.00 -> $81.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/25/2019Cantor FitzgeraldDowngradesSpark Therapeutics (ONCE)Overweight -> Neutral$80.00 -> $114.50N/AView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Cantor FitzgeraldReiteratesHMS (HMSY)Hold $34.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Cantor FitzgeraldReiteratesMomenta Pharmaceuticals (MNTA)Hold $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Cantor FitzgeraldReiteratesCollegium Pharmaceutical (COLL)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Cantor FitzgeraldInitiatesMerck & Co., Inc. (MRK)Overweight $95.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Cantor FitzgeraldReiteratesSarepta Therapeutics (SRPT)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Cantor FitzgeraldReiteratesbluebird bio (BLUE)Neutral -> Neutral$134.00 -> $122.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/21/2019Cantor FitzgeraldReiteratesIntegra Lifesciences (IART)Hold $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/21/2019Cantor FitzgeraldReiteratesCVS Health (CVS)Overweight $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/20/2019Cantor FitzgeraldReiteratesHTG Molecular Diagnostics (HTGM)Buy $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/20/2019Cantor FitzgeraldSet Price TargetReata Pharmaceuticals (RETA)Buy $100.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/20/2019Cantor FitzgeraldReiteratesTivity Health (TVTY)Overweight $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/19/2019Cantor FitzgeraldReiteratesHealthStream (HSTM)Hold $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/19/2019Cantor FitzgeraldReiteratesGalmed Pharmaceuticals (GLMD)Buy $59.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/19/2019Cantor FitzgeraldReiteratesIntercept Pharmaceuticals (ICPT)Buy $170.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/19/2019Cantor FitzgeraldReiteratesPfizer (PFE)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/15/2019Cantor FitzgeraldSet Price TargetBioDelivery Sciences International (BDSI)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/17/2019Cantor FitzgeraldReiteratesSpark Therapeutics (ONCE)Buy $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/15/2019Cantor FitzgeraldReiteratesComputer Programs & Systems (CPSI)Hold $32.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/15/2019Cantor FitzgeraldReiteratesMoody's (MCO)Hold $145.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/15/2019Cantor FitzgeraldReiteratesAcorda Therapeutics (ACOR)Hold $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/15/2019Cantor FitzgeraldReiteratesGlobant (GLOB)Hold $67.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/14/2019Cantor FitzgeraldReiteratesGartner (IT)Hold $141.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/14/2019Cantor FitzgeraldReiteratesVanda Pharmaceuticals (VNDA)Hold -> Reduce $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/12/2019Cantor FitzgeraldReiteratesJazz Pharmaceuticals (JAZZ)Buy $185.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/11/2019Cantor FitzgeraldSet Price TargetAerpio Pharmaceuticals (ARPO)Buy $8.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/11/2019Cantor FitzgeraldReiteratesNuVasive (NUVA)Hold $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/8/2019Cantor FitzgeraldSet Price TargetCollegium Pharmaceutical (COLL)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/8/2019Cantor FitzgeraldReiteratesUniqure (QURE)Buy $68.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/8/2019Cantor FitzgeraldReiteratesVirtusa (VRTU)Buy $62.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/8/2019Cantor FitzgeraldReiteratesBioDelivery Sciences International (BDSI)Buy $5.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/8/2019Cantor FitzgeraldReiteratesFiserv (FISV)Hold $83.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/8/2019Cantor FitzgeraldReiteratesBiohaven Pharmaceutical (BHVN)Buy $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/7/2019Cantor FitzgeraldReiteratesAlnylam Pharmaceuticals (ALNY)Buy $135.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/7/2019Cantor FitzgeraldReiteratesVocera Communications (VCRA)Buy $37.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/7/2019Cantor FitzgeraldRaises TargetFirst Data (FDC)Neutral $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/7/2019Cantor FitzgeraldRaises TargetHealthequity (HQY)Overweight$80.00 -> $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/7/2019Cantor FitzgeraldInitiatesSpectrum Pharmaceuticals (SPPI)Overweight $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2019Cantor FitzgeraldReiteratesArray Biopharma (ARRY)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2019Cantor FitzgeraldDowngradesGartner (IT)Overweight -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2019Cantor FitzgeraldReiteratesRegeneron Pharmaceuticals (REGN)Hold $441.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2019Cantor FitzgeraldReiteratesNeurocrine Biosciences (NBIX)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2019Cantor FitzgeraldDowngradesVanda Pharmaceuticals (VNDA)Overweight -> Neutral$38.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2019Cantor FitzgeraldUpgradesRyanair (RYAAY)Hold -> BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
2/5/2019Cantor FitzgeraldReiteratesAmicus Therapeutics (FOLD)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/5/2019Cantor FitzgeraldReiteratesJack Henry & Associates (JKHY)Buy $163.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/5/2019Cantor FitzgeraldSet Price TargetArray Biopharma (ARRY)Buy $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/5/2019Cantor FitzgeraldReiteratesXencor (XNCR)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/4/2019Cantor FitzgeraldReiteratesEli Lilly And Co (LLY)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
2/4/2019Cantor FitzgeraldReiteratesOptiNose (OPTN)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/4/2019Cantor FitzgeraldReiteratesHalozyme Therapeutics (HALO)Buy $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/4/2019Cantor FitzgeraldInitiatesSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/1/2019Cantor FitzgeraldRaises TargetMsci (MSCI)Buy $188.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/1/2019Cantor FitzgeraldDowngradesCorcept Therapeutics (CORT)Overweight -> Neutral$20.00 -> $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/1/2019Cantor FitzgeraldReiteratesExponent (EXPO)Buy $56.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/1/2019Cantor FitzgeraldReiteratesCymaBay Therapeutics (CBAY)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/31/2019Cantor FitzgeraldReiteratesCelgene (CELG)Buy $100.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/31/2019Cantor FitzgeraldReiteratesNightstar Therapeutics (NITE)Buy $42.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/31/2019Cantor FitzgeraldReiteratesVisa (V)Buy $160.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/29/2019Cantor FitzgeraldReiteratesNeurocrine Biosciences (NBIX)Buy $121.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/29/2019Cantor FitzgeraldReiteratesRoyal Mail (ROYMF)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
1/29/2019Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/29/2019Cantor FitzgeraldSet Price TargetAcelRx Pharmaceuticals (ACRX)Buy $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/29/2019Cantor FitzgeraldSet Price TargetProQR Therapeutics (PRQR)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/29/2019Cantor FitzgeraldInitiatesAmicus Therapeutics (FOLD)Overweight $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/29/2019Cantor FitzgeraldDowngradesDenali Therapeutics (DNLI)Overweight -> Neutral $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/29/2019Cantor FitzgeraldReiteratesNovavax (NVAX)Hold $2.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/28/2019Cantor FitzgeraldReiteratesArena Pharmaceuticals (ARNA)Buy $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/28/2019Cantor FitzgeraldInitiatesTheravance Biopharma (TBPH)Buy $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/25/2019Cantor FitzgeraldSet Price TargetBioDelivery Sciences International (BDSI)Buy $5.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/25/2019Cantor FitzgeraldSet Price TargetCollegium Pharmaceutical (COLL)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/25/2019Cantor FitzgeraldSet Price TargetZimmer Biomet (ZBH)Buy $135.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/25/2019Cantor FitzgeraldSet Price TargetEmergent Biosolutions (EBS)Buy $75.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/25/2019Cantor FitzgeraldReiteratesIntuitive Surgical (ISRG)Buy $620.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/23/2019Cantor FitzgeraldInitiatesAscendis Pharma A/S (ASND)Overweight -> Overweight $102.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/23/2019Cantor FitzgeraldSet Price TargetAlkermes (ALKS)Hold $33.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/23/2019Cantor FitzgeraldReiteratesRigel Pharmaceuticals (RIGL)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/23/2019Cantor FitzgeraldReiterateseHealth (EHTH)Overweight $56.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldReiteratesAerpio Pharmaceuticals (ARPO)OverweightMediumView Rating Details  Share on Twitter  Share on StockTwits
1/22/2019Cantor FitzgeraldInitiatesInsys Therapeutics (INSY)Overweight $4.40HighView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldReiteratesStryker (SYK)NeutralMediumView Rating Details  Share on Twitter  Share on StockTwits
1/21/2019Cantor FitzgeraldReiteratesTherapeuticsMD (TXMD)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldSet Price TargetZimmer Biomet (ZBH)Buy $135.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldSet Price TargetGlobus Medical (GMED)Buy $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldSet Price TargetOrthofix Medical (OFIX)Buy $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldSet Price TargetAxoGen (AXGN)Buy $26.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019Cantor FitzgeraldReiteratesZimmer Biomet (ZBH)OverweightN/AView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldRaises TargetWNS (WNS)Outperform -> Overweight $61.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldInitiatesAerpio Pharmaceuticals (ARPO)Overweight $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019Cantor FitzgeraldReiteratesIBM (IBM)Hold $140.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019Cantor FitzgeraldReiteratesFiserv (FISV)Hold $73.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019Cantor FitzgeraldReiteratesAptinyx (APTX)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019Cantor FitzgeraldReiteratesExponent (EXPO)Buy $56.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019Cantor FitzgeraldReiteratesIHS Markit (INFO)Hold $51.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019Cantor FitzgeraldInitiatesArray Biopharma (ARRY)Overweight $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019Cantor FitzgeraldReiteratesUnitedHealth Group (UNH)Buy $310.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019Cantor FitzgeraldReiteratesHTG Molecular Diagnostics (HTGM)Buy $7.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019Cantor FitzgeraldSet Price TargetKindred Biosciences (KIN)Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019Cantor FitzgeraldSet Price TargetWright Medical Group (WMGI)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019Cantor FitzgeraldReiteratesPolarityte (PTE)Buy $65.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/13/2019Cantor FitzgeraldReiteratesCoupa Software (COUP)Buy $92.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/13/2019Cantor FitzgeraldReiteratesFactSet Research Systems (FDS)Hold $209.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/10/2019Cantor FitzgeraldSet Price TargetSupernus Pharmaceuticals (SUPN)Buy $57.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019Cantor FitzgeraldReiteratesInfosys (INFY)Hold $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019Cantor FitzgeraldReiteratesCorbus Pharmaceuticals (CRBP)Overweight -> Overweight$36.00 -> $38.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019Cantor FitzgeraldReiteratesVocera Communications (VCRA)Overweight $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/10/2019Cantor FitzgeraldReiteratesSpark Therapeutics (ONCE)Overweight -> Overweight$103.00 -> $80.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/10/2019Cantor FitzgeraldReiteratesNightstar Therapeutics (NITE)Overweight -> Overweight$36.00 -> $42.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/9/2019Cantor FitzgeraldReiteratesAridis Pharmaceuticals (ARDS)Buy $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/9/2019Cantor FitzgeraldReiteratesGlobus Medical (GMED)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019Cantor FitzgeraldSet Price TargetIntegra Lifesciences (IART)Hold $54.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019Cantor FitzgeraldSet Price TargetOrthofix Medical (OFIX)Buy $66.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019Cantor FitzgeraldReiteratesRigel Pharmaceuticals (RIGL)Buy $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesPTC Therapeutics (PTCT)Buy $61.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesDXC Technology (DXC)Hold $70.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesCollegium Pharmaceutical (COLL)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesBioMarin Pharmaceutical (BMRN)Buy $126.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesSeaSpine (SPNE)Buy $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesTeladoc Health (TDOC)Hold $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/4/2019Cantor FitzgeraldSet Price TargetEmergent Biosolutions (EBS)Buy $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/4/2019Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/4/2019Cantor FitzgeraldSet Price TargetJazz Pharmaceuticals (JAZZ)Buy $201.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/3/2019Cantor FitzgeraldReiteratesCVS Health (CVS)Buy $96.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/3/2019Cantor FitzgeraldReiteratesCelgene (CELG)Buy $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/2/2019Cantor FitzgeraldReiteratesHumana (HUM)Hold $325.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/2/2019Cantor FitzgeraldSet Price TargetAcorda Therapeutics (ACOR)Hold $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/31/2018Cantor FitzgeraldReiteratesHeron Therapeutics (HRTX)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/31/2018Cantor FitzgeraldReiteratesEvolent Health (EVH)Buy $37.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/26/2018Cantor FitzgeraldSet Price TargetNeos Therapeutics (NEOS)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/26/2018Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/26/2018Cantor FitzgeraldSet Price TargetMarinus Pharmaceuticals (MRNS)Buy $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/27/2018Cantor FitzgeraldSet Price TargetBioDelivery Sciences International (BDSI)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Cantor FitzgeraldSet Price TargetPolarityte (PTE)Buy $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Cantor FitzgeraldSet Price TargetANI Pharmaceuticals (ANIP)Buy $74.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Cantor FitzgeraldSet Price TargetDermira (DERM)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/30/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/27/2018Cantor FitzgeraldInitiatesTAIWAN LIPOSOME/S (TLC)Overweight $11.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/26/2018Cantor FitzgeraldReiteratesAridis Pharmaceuticals (ARDS)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/24/2018Cantor FitzgeraldSet Price TargetAcorda Therapeutics (ACOR)Hold ACOR $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Cantor FitzgeraldSet Price TargetShire (SHPG)Buy $222.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Cantor FitzgeraldSet Price TargetPerrigo (PRGO)Buy PRGO $107.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Cantor FitzgeraldSet Price TargetViewray (VRAY)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/21/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/21/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Cantor FitzgeraldReiteratesDeciphera Pharmaceuticals (DCPH)Buy $53.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Cantor FitzgeraldReiteratesApellis Pharmaceuticals (APLS)Buy $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldReiteratesKrystal Biotech (KRYS)Buy $34.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldReiteratesAxoGen (AXGN)Buy $43.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldDowngradesHi-Crush Partners (HCLP)Neutral -> UnderweightHighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldLowers TargetFactSet Research Systems (FDS)Neutral $209.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldReiteratesGilead Sciences (GILD)Overweight $92.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldInitiatesGALAPAGOS NV/S (GLPG)Overweight -> Overweight $130.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/18/2018Cantor FitzgeraldReiteratesCerus (CERS)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/18/2018Cantor FitzgeraldRaises TargetPuma Biotechnology (PBYI) $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldReiteratesCastlight Health (CSLT)Buy $5.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldUpgradesHealthequity (HQY)Neutral -> Overweight $82.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldSet Price TargetZynerba Pharmaceuticals (ZYNE)Buy $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldSet Price TargetOvid Therapeutics (OVID)Buy $10.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldReiteratesVertex Pharmaceuticals (VRTX)Buy $217.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldReiteratesWellCare Health Plans (WCG)Buy $330.00HighView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Wednesday at 07:17 PM ET.

MarketBeat Community Rating for Cantor Fitzgerald

Community Ranking:  1.8 out of 5 (star half star)
Outperform Votes:  12,073 (Vote Outperform)
Underperform Votes:  22,148 (Vote Underperform)
Total Votes:  34,221
MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel